PDL BIOPHARMA, INC. Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of income

In millions of USD; shares in millions, except per-share amounts

	FY2020 3 months to Sep 30, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 0 months to Jan 7, 2018	FY2016 12 months to Dec 31, 2016
Revenues
Revenue from Contract with Customer, Including Assessed Tax
Product Revenue
Service
Operating Lease, Lease Income
Queen et al. patents
Acquired rights
License and other
Total revenues
Interest revenue
Product revenue, net

Operating expenses
Cost of Revenue
Cost, Amortization
Amortization of Intangible Assets
Business Exit Costs
General and Administrative Expense
Selling and Marketing Expense
Research and Development Expense
Impairment of Intangible Assets, Finite-lived
Asset Impairment Charges
Acquisition-related costs
Loss on extinguishment of notes receivable
Change in fair value of contingent consideration
Total operating expenses
Operating income
Non-operating expense, net
Interest and other income, net
Interest expense
Unrealized Gain (Loss) on Investments
Gain (Loss) on Disposition of Assets
Business Combination, Bargain Purchase, Gain Recognized, Amount
Gain (Loss) on Investments
Gain (loss) on extinguishment of debt
Total non-operating expense, net
Income before income taxes
Income tax expense
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax
Discontinued Operation, Tax Effect of Discontinued Operation
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net Income (Loss) Attributable to Noncontrolling Interest
Net income attributable to noncontrolling interests
Net income per share
Income (Loss) from Continuing Operations, Per Basic Share
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share
Basic (in Dollars per Share)
Income (Loss) from Continuing Operations, Per Diluted Share
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share
Diluted (in Dollars per Share)
Weighted average shares outstanding
Basic (in Shares)
Diluted (in Shares)
Cash dividends declared per common share (in Dollars per Share)

Comments